<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03382821</url>
  </required_header>
  <id_info>
    <org_study_id>105766</org_study_id>
    <nct_id>NCT03382821</nct_id>
  </id_info>
  <brief_title>Comparative Trial Via Tranforaminal Approach Versus Epidural Catheter Via Interlaminar Approach</brief_title>
  <official_title>A Prospective Randomized Comparative Trial of Targeted Injection Via a Transforaminal Approach With Dexamethasone Versus an Epidural Catheter Via an Interlaminar Approach With Particulate Steroid for the Treatment of Cervical Radicular Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Epimed</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Do cervical epidural steroid injections done by transforaminal catheter targeted approach
      improve pain and function in patients with cervical radicular pain?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two distinct techniques used to administer epidural steroids specifically to the nerve root
      affected in a radicular pain syndrome, which include transforaminal access at the level of
      pathology and interlaminar interlaminar access at the C7-T1 level with subsequent advancement
      of an epidural cathether to the level of pathology. Use of an epidural catheter is necessary
      in order to achieve a targeted injection via an interlaminar approach in order to prevent
      dural puncture or direct spinal cord trauma. Anatomic studies confirm the distance between
      the ligamentum flavum and dura is on average, 4 mm at the C7-T1 or C6-C7 levels, but 1mm or
      smaller at C5-C6 and more rostral levels. Therefore, there is likely greater risk of dural
      puncture and spinal cord injury when &quot;targeting&quot; steroid delivery using only the interlaminar
      technique directly at the level where pathology is located (C4-C5, or C5-C6, for example).
      Thus, the interlaminar placement of a needle rostral to the C6-C7 level has been strongly
      discouraged.

      Both the transforaminal injection approach and the targeted catheter approach demonstrate
      effectiveness. Studies have demonstrated the effectiveness of transforaminal epidural steroid
      injection for the treatment of cervical radicular pain. Our own recent work demonstrates the
      clinical effectiveness of the catheter-based targeted approach. However, these two approaches
      have never been directly compared. Thus, we aim to compare the differences in pain reduction,
      medication utilization, functional outcomes, patient satisfaction, and surgical rate
      reduction between these two approaches to the treatment of cervical radicular pain.

      Cervical radicular pain is a common syndrome, often treated with epidural steroid injection
      (ESI). An approach that targets the therapeutic agent, corticosteroid, at the site of spinal
      pathology can be performed via a transforaminal approach or via a interlaminar approach at
      C7-T1 with subsequent epidural catheter advancement to the symptomatic level. There are no
      universal guidelines that recommend the use of one technique over the other. We will directly
      compare the clinical effectiveness of these two approaches as measured by pain reduction,
      medication utilization, functional outcomes, patient satisfaction, and surgical rate
      reduction. The results of this study will potentially influence clinical practice
      recommendations regarding the treatment of cervical radicular pain. If one technique proves
      superior, instating this technique will have implications potentially for reducing opioid
      use, surgery and other healthcare utilization, and general healthcare cost related to the
      treatment of cervical radicular pain.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2018</start_date>
  <completion_date type="Anticipated">January 14, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, randomized, comparative trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Each subject will be randomized into a group assignment in a 1:1 manner, #1 or #2, as outlined in the Methods section</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Reduction Amount</measure>
    <time_frame>1 month follow up</time_frame>
    <description>Pain Reduction 50% or greater with NRS scale (0-10) for neck and arm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scale median</measure>
    <time_frame>2 week, 1 month, 3 month, 6 month, and 1 year follow up</time_frame>
    <description>Reduction in median NRS (0-10) pain score (both neck pain and arm pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neck Disability Index</measure>
    <time_frame>2 week, 1 month, 3 month, 6 month, and 1 year follow up</time_frame>
    <description>5 questions that make up the neck disability index (NDI-5).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current pain medication</measure>
    <time_frame>2 week, 1 month, 3 month, 6 month, and 1 year follow up</time_frame>
    <description>Pain medication changes throughout treatment using MQS III calculator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change</measure>
    <time_frame>2 week, 1 month, 3 month, 6 month, and 1 year follow up</time_frame>
    <description>7 point question called Patient Global Impression of Change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Responder analysis</measure>
    <time_frame>1 year</time_frame>
    <description>include the proportion of patients with 30% or greater improvement on the NDI-5, a PGIC score less than 3 (indicating &quot;improved&quot; or &quot;very much improved&quot;), a 6.8 or greater point reduction on the MQS III score (equivalent to approximately 10 daily morphine equivalents), and the proportion of participants who undergo surgical spine surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cervical Radiculopathy</condition>
  <arm_group>
    <arm_group_label>Transforaminal ESI with dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 1: Transforaminal cervical ESI with dexamethasone sodium phosphate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transforaminal catheter-targeted ESI with triamcinolone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 2: Catheter-targeted cervical ESI with triamcinolone acetonide</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transforaminal ESI with dexamethasone</intervention_name>
    <description>Catheter-targeted ESI via interlaminar access at the C7-T1 level with dexamethasone sodium phosphate 1.5 mL (10 mg/mL) and 1 ml 1% lidocaine (total volume 2.5 mL).</description>
    <arm_group_label>Transforaminal ESI with dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transforaminal catheter-targeted ESI with triamcinolone</intervention_name>
    <description>Catheter-targeted ESI via interlaminar access at the C7-T1 level with triamcinolone acetonide 2 mL (40mg/mL) and 1 ml 1% lidocaine (total volume 3 mL).</description>
    <arm_group_label>Transforaminal catheter-targeted ESI with triamcinolone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone Sodium Phosphate 10 MG/ML</intervention_name>
    <description>Transforaminal ESI with dexamethasone 1.5 mL of dexamethasone sodium phosphate in group #1</description>
    <arm_group_label>Transforaminal ESI with dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>1 mL of 1% lidocaine as diluent for the steroid in both group #1 and group #2</description>
    <arm_group_label>Transforaminal ESI with dexamethasone</arm_group_label>
    <arm_group_label>Transforaminal catheter-targeted ESI with triamcinolone</arm_group_label>
    <other_name>Xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone Acetonide 40mg/mL</intervention_name>
    <description>Transforaminal catheter-targeted ESI with triamcinolone acetonide 2 mL in group #2</description>
    <arm_group_label>Transforaminal catheter-targeted ESI with triamcinolone</arm_group_label>
    <other_name>Kenalog</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-80.

          -  Clinical diagnosis of unilateral C4-C8 radicular pain.

          -  Magnetic resonance imaging pathology consistent with clinical symptoms/signs.

          -  Numerical Rating Scale (NRS) pain score of 4 or higher.

          -  Pain duration of more than 6 weeks despite trial of conservative therapy (medications,
             physical therapy, or chiropractic care).

        Exclusion Criteria:

          -  Refusal to participate, provide consent, or provide follow-up information for the
             6-month duration of the study.

          -  Contraindications to Cervical ESI (active infection, bleeding disorders, current
             anticoagulant or antiplatelet medication use, allergy to medications used for CIESI,
             and pregnancy).

          -  Cervical spinal cord lesions; cerebrovascular, demyelinating, or other neuro-muscular
             muscular disease.

          -  Current glucocorticoid use or ESI within past 6 months.

          -  Prior cervical spine surgery.

          -  Patient request for or requirement of conscious sedation for the injection procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zachary L McCormick, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shellie S Cunningham, BS</last_name>
    <phone>801-587-5488</phone>
    <email>shellie.cunningham@hsc.utah.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Matthew J Brobeck, AS</last_name>
    <phone>801-587-5488</phone>
    <email>matthew.brobeck@hsc.utah.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shellie S Cunningham, BS</last_name>
      <phone>801-587-5488</phone>
      <email>shellie.cunningham@hsc.utah.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Radhakrishnan K, Litchy WJ, O'Fallon WM, Kurland LT. Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain. 1994 Apr;117 ( Pt 2):325-35.</citation>
    <PMID>8186959</PMID>
  </reference>
  <reference>
    <citation>Carette S, Fehlings MG. Clinical practice. Cervical radiculopathy. N Engl J Med. 2005 Jul 28;353(4):392-9. Review.</citation>
    <PMID>16049211</PMID>
  </reference>
  <reference>
    <citation>Heckmann JG, Lang CJ, Zöbelein I, Laumer R, Druschky A, Neundörfer B. Herniated cervical intervertebral discs with radiculopathy: an outcome study of conservatively or surgically treated patients. J Spinal Disord. 1999 Oct;12(5):396-401.</citation>
    <PMID>10549703</PMID>
  </reference>
  <reference>
    <citation>Johnston MM, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: implications for headache disorders. Ann Neurol. 2013 Jul;74(1):145-8. doi: 10.1002/ana.23869. Epub 2013 Jun 17.</citation>
    <PMID>23424170</PMID>
  </reference>
  <reference>
    <citation>Mizutamari M, Sei A, Tokiyoshi A, Fujimoto T, Taniwaki T, Togami W, Mizuta H. Corresponding scapular pain with the nerve root involved in cervical radiculopathy. J Orthop Surg (Hong Kong). 2010 Dec;18(3):356-60.</citation>
    <PMID>21187551</PMID>
  </reference>
  <reference>
    <citation>Rhee JM, Yoon T, Riew KD. Cervical radiculopathy. J Am Acad Orthop Surg. 2007 Aug;15(8):486-94. Review.</citation>
    <PMID>17664368</PMID>
  </reference>
  <reference>
    <citation>Malanga GA. The diagnosis and treatment of cervical radiculopathy. Med Sci Sports Exerc. 1997 Jul;29(7 Suppl):S236-45. Review.</citation>
    <PMID>9247921</PMID>
  </reference>
  <reference>
    <citation>Renfrew DL, Moore TE, Kathol MH, el-Khoury GY, Lemke JH, Walker CW. Correct placement of epidural steroid injections: fluoroscopic guidance and contrast administration. AJNR Am J Neuroradiol. 1991 Sep-Oct;12(5):1003-7.</citation>
    <PMID>1719788</PMID>
  </reference>
  <reference>
    <citation>Mehta M, Salmon N. Extradural block. Confirmation of the injection site by X-ray monitoring. Anaesthesia. 1985 Oct;40(10):1009-12.</citation>
    <PMID>4061788</PMID>
  </reference>
  <reference>
    <citation>Stojanovic MP, Vu TN, Caneris O, Slezak J, Cohen SP, Sang CN. The role of fluoroscopy in cervical epidural steroid injections: an analysis of contrast dispersal patterns. Spine (Phila Pa 1976). 2002 Mar 1;27(5):509-14.</citation>
    <PMID>11880836</PMID>
  </reference>
  <reference>
    <citation>Van Zundert J, Huntoon M, Patijn J, Lataster A, Mekhail N, van Kleef M; Pain Practice. 4. Cervical radicular pain. Pain Pract. 2010 Jan-Feb;10(1):1-17. doi: 10.1111/j.1533-2500.2009.00319.x. Epub 2009 Oct 5. Review.</citation>
    <PMID>19807874</PMID>
  </reference>
  <reference>
    <citation>Johansson A, Hao J, Sjölund B. Local corticosteroid application blocks transmission in normal nociceptive C-fibres. Acta Anaesthesiol Scand. 1990 Jul;34(5):335-8.</citation>
    <PMID>2167604</PMID>
  </reference>
  <reference>
    <citation>Benyamin RM, Singh V, Parr AT, Conn A, Diwan S, Abdi S. Systematic review of the effectiveness of cervical epidurals in the management of chronic neck pain. Pain Physician. 2009 Jan-Feb;12(1):137-57. Review.</citation>
    <PMID>19165300</PMID>
  </reference>
  <reference>
    <citation>Stav A, Ovadia L, Sternberg A, Kaadan M, Weksler N. Cervical epidural steroid injection for cervicobrachialgia. Acta Anaesthesiol Scand. 1993 Aug;37(6):562-6.</citation>
    <PMID>8213020</PMID>
  </reference>
  <reference>
    <citation>Castagnera L, Maurette P, Pointillart V, Vital JM, Erny P, Sénégas J. Long-term results of cervical epidural steroid injection with and without morphine in chronic cervical radicular pain. Pain. 1994 Aug;58(2):239-43.</citation>
    <PMID>7816491</PMID>
  </reference>
  <reference>
    <citation>Saal JS, Saal JA, Yurth EF. Nonoperative management of herniated cervical intervertebral disc with radiculopathy. Spine (Phila Pa 1976). 1996 Aug 15;21(16):1877-83.</citation>
    <PMID>8875719</PMID>
  </reference>
  <reference>
    <citation>Riew KD, Yin Y, Gilula L, Bridwell KH, Lenke LG, Lauryssen C, Goette K. The effect of nerve-root injections on the need for operative treatment of lumbar radicular pain. A prospective, randomized, controlled, double-blind study. J Bone Joint Surg Am. 2000 Nov;82-A(11):1589-93.</citation>
    <PMID>11097449</PMID>
  </reference>
  <reference>
    <citation>Buttermann GR. Treatment of lumbar disc herniation: epidural steroid injection compared with discectomy. A prospective, randomized study. J Bone Joint Surg Am. 2004 Apr;86-A(4):670-9.</citation>
    <PMID>15069129</PMID>
  </reference>
  <reference>
    <citation>Huntoon MA. Anatomy of the cervical intervertebral foramina: vulnerable arteries and ischemic neurologic injuries after transforaminal epidural injections. Pain. 2005 Sep;117(1-2):104-11.</citation>
    <PMID>16055268</PMID>
  </reference>
  <reference>
    <citation>Abbasi A, Malhotra G, Malanga G, Elovic EP, Kahn S. Complications of interlaminar cervical epidural steroid injections: a review of the literature. Spine (Phila Pa 1976). 2007 Sep 1;32(19):2144-51. Review.</citation>
    <PMID>17762818</PMID>
  </reference>
  <reference>
    <citation>Rathmell JP, Benzon HT, Dreyfuss P, Huntoon M, Wallace M, Baker R, Riew KD, Rosenquist RW, Aprill C, Rost NS, Buvanendran A, Kreiner DS, Bogduk N, Fourney DR, Fraifeld E, Horn S, Stone J, Vorenkamp K, Lawler G, Summers J, Kloth D, O'Brien D Jr, Tutton S. Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. Anesthesiology. 2015 May;122(5):974-84. doi: 10.1097/ALN.0000000000000614. Review.</citation>
    <PMID>25668411</PMID>
  </reference>
  <reference>
    <citation>McCormick ZL, Nelson A, Bhave M, Zhukalin M, Kendall M, McCarthy RJ, Khan D, Nagpal G, Walega DR. A Prospective Randomized Comparative Trial of Targeted Steroid Injection Via Epidural Catheter Versus Standard C7-T1 Interlaminar Approach for the Treatment of Unilateral Cervical Radicular Pain. Reg Anesth Pain Med. 2017 Jan/Feb;42(1):82-89. doi: 10.1097/AAP.0000000000000521.</citation>
    <PMID>27922950</PMID>
  </reference>
  <reference>
    <citation>Ackerman WE 3rd, Ahmad M. The efficacy of lumbar epidural steroid injections in patients with lumbar disc herniations. Anesth Analg. 2007 May;104(5):1217-22, tables of contents.</citation>
    <PMID>17456677</PMID>
  </reference>
  <reference>
    <citation>Gharibo CG, Varlotta GP, Rhame EE, Liu EC, Bendo JA, Perloff MD. Interlaminar versus transforaminal epidural steroids for the treatment of subacute lumbar radicular pain: a randomized, blinded, prospective outcome study. Pain Physician. 2011 Nov-Dec;14(6):499-511.</citation>
    <PMID>22086091</PMID>
  </reference>
  <reference>
    <citation>Schaufele MK, Hatch L, Jones W. Interlaminar versus transforaminal epidural injections for the treatment of symptomatic lumbar intervertebral disc herniations. Pain Physician. 2006 Oct;9(4):361-6.</citation>
    <PMID>17066121</PMID>
  </reference>
  <reference>
    <citation>Deyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, Carrino J, Chou R, Cook K, DeLitto A, Goertz C, Khalsa P, Loeser J, Mackey S, Panagis J, Rainville J, Tosteson T, Turk D, Von Korff M, Weiner DK. Focus article: report of the NIH Task Force on Research Standards for Chronic Low Back Pain. Eur Spine J. 2014 Oct;23(10):2028-45. doi: 10.1007/s00586-014-3540-3.</citation>
    <PMID>25212440</PMID>
  </reference>
  <reference>
    <citation>Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, Farrar JT, Hertz S, Raja SN, Rappaport BA, Rauschkolb C, Sampaio C. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain. 2009 Dec;146(3):238-44. doi: 10.1016/j.pain.2009.08.019. Review.</citation>
    <PMID>19836888</PMID>
  </reference>
  <reference>
    <citation>Kovacs FM, Abraira V, Royuela A, Corcoll J, Alegre L, Tomás M, Mir MA, Cano A, Muriel A, Zamora J, Del Real MT, Gestoso M, Mufraggi N; Spanish Back Pain Research Network. Minimum detectable and minimal clinically important changes for pain in patients with nonspecific neck pain. BMC Musculoskelet Disord. 2008 Apr 10;9:43. doi: 10.1186/1471-2474-9-43.</citation>
    <PMID>18402665</PMID>
  </reference>
  <reference>
    <citation>Gallizzi M, Gagnon C, Harden RN, Stanos S, Khan A. Medication Quantification Scale Version III: internal validation of detriment weights using a chronic pain population. Pain Pract. 2008 Jan-Feb;8(1):1-4. doi: 10.1111/j.1533-2500.2007.00163.x.</citation>
    <PMID>18211588</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2017</study_first_submitted>
  <study_first_submitted_qc>December 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 26, 2017</study_first_posted>
  <last_update_submitted>December 18, 2017</last_update_submitted>
  <last_update_submitted_qc>December 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cervical epidural steroid injection</keyword>
  <keyword>transforaminal approach</keyword>
  <keyword>epidural catheter targeted</keyword>
  <keyword>interlaminar approach</keyword>
  <keyword>cervical radicular pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiculopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

